October 2021 “Hybrid” Meeting – Abbvie


  • October 7, 2021
    6:30 pm - 9:30 pm

We’re excited to announce our first “hybrid” in-person & virtual meeting this October. Presentation Topic: Oriahnn An Oral Treatment for Heavy Bleeding Due to Fibroids in Premenopausal Women PRESENTED BY DENNIS SONG, President of Denton County Pharmacy Association HOSTED BY AARON AUSTIN OF ABBVIE Location: 2440 Parkwood Blvd, Frisco, TX 75034 Date & Time: Thursday, October Read moreOctober 2021 “Hybrid” Meeting – Abbvie

2021.09 DAPA’s Annual Kick-Off Meeting

We're sorry, but all tickets sales have ended because the event is expired.

  • September 2, 2021
    6:30 pm - 8:00 pm

 This meeting is a VIRTUAL MEETING. We would love to see you at our virtual meeting in September. Please join us as we welcome our incoming officers and board members at the installation following the meeting. Debbie Garza, RPh, CEO of Texas Pharmacy Association will also give us updates from the TPA. Please stay Read more2021.09 DAPA’s Annual Kick-Off Meeting

DAPA & AbbVie – Women’s Health Sessions – Session 2 – Thursday, June 24

We're sorry, but all tickets sales have ended because the event is expired.

  • June 24, 2021
    6:00 pm - 7:00 pm

WEBINAR 2: Thursday, June 24 – 6PM CT UTERINE FIBROIDS & Elagolix+Estradiol/NETA, indicated for heavy menstrual bleeding associated with uterine leiomyomas in pre-menopausal women Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids Read moreDAPA & AbbVie – Women’s Health Sessions – Session 2 – Thursday, June 24

DAPA & AbbVie – Women’s Health Sessions – Session 1 – Wednesday, June 23

We're sorry, but all tickets sales have ended because the event is expired.

  • June 23, 2021
    6:00 pm - 7:00 pm

  WEBINAR 1: Wednesday, June 23, 2021 – 6PM CT  Endometriosis and Elagolix, indicated for moderate to severe endometriosis pain. One of the most common gynecologic disorders in the U.S., and affecting  roughly 10% (190 million) of reproductive age women and girls worldwide, endometriosis is a highly estrogen-dependent, chronic, inflammatory disease characterized by the growth Read moreDAPA & AbbVie – Women’s Health Sessions – Session 1 – Wednesday, June 23

May 2021 – Rhythm Pharmaceuticals – DAPA – Rare Genetic Diseases of Obesity: Challenges and Patient Cases

We're sorry, but all tickets sales have ended because the event is expired.

  • May 6, 2021
    6:30 pm - 8:30 pm

Rare Genetic Diseases of Obesity:   Challenges and Patient Cases – Virtual Meeting Thursday, May 6, 2021 6:30 PM The disease education event will explain the role of the hypothalamic signaling pathway in appetite, energy and weight regulation.  The presentation will include how impairments in the melanocortin-4 receptor (MC4R) pathway may lead to insatiable hunger and Read moreMay 2021 – Rhythm Pharmaceuticals – DAPA – Rare Genetic Diseases of Obesity: Challenges and Patient Cases

AbbVie – Thursday, April 1st – Women’s Health – Oriahnn

We're sorry, but all tickets sales have ended because the event is expired.

  • April 1, 2021
    12:30 pm - 1:30 pm

AbbVie – Thursday, April 1st – Women’s Health – Oriahnn Dear DAPA members, The AbbVie Women’s Health Organization is pleased to connect with the community of Pharmacists in the Dallas area. We recognize your pharmacies provide services that cover a wide variety of medications, for diverse disease states, patient monitoring, and frequent communications with a Read moreAbbVie – Thursday, April 1st – Women’s Health – Oriahnn

AbbVie – Wednesday, March 31st – Women’s Health – Oriahnn

We're sorry, but all tickets sales have ended because the event is expired.

  • March 31, 2021
    6:00 pm - 7:00 pm

AbbVie – Wednesday, March 31st – Women’s Health Dear DAPA members, The AbbVie Women’s Health Organization is pleased to connect with the community of Pharmacists in the Dallas area. We recognize your pharmacies provide services that cover a wide variety of medications, for diverse disease states, patient monitoring, and frequent communications with a diversity of Read moreAbbVie – Wednesday, March 31st – Women’s Health – Oriahnn

April 2021 DAPA Meeting – AstraZeneca – Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)

We're sorry, but all tickets sales have ended because the event is expired.

  • April 8, 2021 - April 12, 2021
    6:30 pm

  You’re invited to join our April 2021 Meeting! Title Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF) Presented by Jessica Hart, PharmD, BCACP – Medical Science Liaison, Cardiovascular and Metabolic – North Texas, Oklahoma, AstraZeneca When Thursday, April 8, 2021 at 6:30 PM This is a VIRTUAL meeting Are Read moreApril 2021 DAPA Meeting – AstraZeneca – Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)

March 2021 Prescribing and Monitoring Controlled Substances TSBP Required 1 Hr CE

We're sorry, but all tickets sales have ended because the event is expired.

  • March 4, 2021
    6:30 pm - 8:00 pm

Dallas Area Pharmacy Association and Texas Pharmacy Association Presents: An Overview of the Opioid Epidemic and Pharmacy’s Role in Addressing Prescription Drug Abuse Presented by:  Lisa D. Sullivan Drug Diversion – Safety Implication DEA Dallas Field Division When: THURSDAY, MARCH 4, 2021 AT 6:30 PM PLEASE READ: This Texas State Board of Pharmacy required Prescribing Read moreMarch 2021 Prescribing and Monitoring Controlled Substances TSBP Required 1 Hr CE